| Date Filed | Type | Description |
| 02/05/2015 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS LP reports a 0% stake in MAXYGEN INC |
| 02/10/2014 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS LP reports a 8.5% stake in MAXYGEN INC |
| 01/29/2014 |
SC 13G/A
| BlackRock Inc. reports a 7.1% stake in MAXYGEN INC. |
| 11/06/2013 |
NO ACT
| Form NO ACT - No Action Letter |
| 11/06/2013 |
NO ACT
| Form NO ACT - No Action Letter |
| 11/06/2013 |
NO ACT
| Form NO ACT - No Action Letter |
| 11/06/2013 |
NO ACT
| Form NO ACT - No Action Letter |
| 11/01/2013 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 09/23/2013 |
SC 13G
| Yakira Capital Management, Inc. reports a 5.3% stake in Maxygen, Inc. |
| 08/30/2013 |
8-K
| Quarterly results |
| 08/29/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 08/21/2013 |
SC 13G/A
| Weiss Asset Management LP reports a 7.6% stake in Maxygen, Inc. |
| 08/13/2013 |
4
| Borkholder John (General Counsel & Secretary) has filed a Form 4 on MAXYGEN INC|
Txns:
| Paid exercise price by delivering 5,096 shares
@ $2.55, valued at
$13k
|
|
| 08/13/2013 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications t... |
| 08/07/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 08/07/2013 |
8-K
| Quarterly results |
| 07/03/2013 |
SC 13G
| Weiss Asset Management LP reports a 6.8% stake in Maxygen, Inc. |
| 07/01/2013 |
4
| SULAT JAMES R (Former CEO & CFO) has filed a Form 4 on MAXYGEN INC|
Txns:
| Exercised 57,162 shares
@ $0
Disposed/sold 57,162 shares
@ $0 |
|
| 06/28/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/28/2013 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 06/24/2013 |
4
| Borkholder John (General Counsel & Secretary) has filed a Form 4 on MAXYGEN INC|
Txns:
| Paid exercise price by delivering 1,490 shares
@ $2.49, valued at
$3.7k
|
|
| 06/03/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 05/03/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 05/03/2013 |
8-K
| Quarterly results |
| 04/19/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 03/25/2013 |
4
| Borkholder John (General Counsel & Secretary) has filed a Form 4 on MAXYGEN INC|
Txns:
| Paid exercise price by delivering 2,769 shares
@ $2.42, valued at
$6.7k
|
|
| 03/12/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/12/2013 |
8-K
| Quarterly results |
| 02/13/2013 |
SC 13G/A
| Alistair Capital Management, L.L.C. reports a 0.9% stake in Maxygen, Inc. |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/26/2012 |
4
| Borkholder John (General Counsel & Secretary) has filed a Form 4 on MAXYGEN INC|
Txns:
| Paid exercise price by delivering 1,855 shares
@ $2.48, valued at
$4.6k
|
|
| 11/16/2012 |
8-K
| Other Events |
| 11/06/2012 |
10-Q
| Quarterly Report for the period ended September 30, 2012 |
| 11/06/2012 |
8-K
| Quarterly results |
|